Literature DB >> 31183740

Early Interaction of Alternaria infectoria Conidia with Macrophages.

M C Almeida1, D Antunes2, B M A Silva2, L Rodrigues2,3, M Mota2,3, O Borges2,4, C Fernandes2, T Gonçalves2,3.   

Abstract

Fungi of the genus Alternaria are ubiquitous indoor and outdoor airborne agents, and individuals are daily exposed to their spores. Although its importance in human infections and, particularly in respiratory allergies, there are no studies of how Alternaria spp. spores interact with host cells. Our aim was to study the early interaction of Alternaria infectoria spores with macrophages, the first line of immune defense. RAW 264.7 macrophages were infected with A. infectoria conidia, and the internalization and viability of conidia once inside the macrophages were quantified during the first 6 h of interaction. Live cell imaging was used to study the dynamics of this interaction. TNF-α production was quantified by relative gene expression, and the concentration of other cytokines (IL-1α, IL-1β, IL-6, IL-4, IL-10, IL-17, GM-CSF and INF-γ) and a chemokine, MIP-1α, was quantified by ELISA. Conidia were rapidly internalized by macrophages, with approximately half internalized after 30 min of interaction. During the first 6 h of interaction, macrophages retained the ability to mitotically divide while containing internalized conidia. The classical macrophage-activated morphology was absent in macrophages infected with conidia, and TNF-α and other cytokines and chemokines failed to be produced. Thus, macrophages are able to efficiently phagocyte A. infectoria conidia, but, during the first 6 h, no effective antifungal response is triggered, therefore promoting the residence of these fungal conidia inside the macrophages.

Entities:  

Keywords:  Alternaria infectoria; Conidia; Infection; Macrophages

Mesh:

Substances:

Year:  2019        PMID: 31183740     DOI: 10.1007/s11046-019-00339-6

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  40 in total

Review 1.  Cytokines in host defense against Aspergillus: recent advances.

Authors:  A P Phadke; B Mehrad
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Marilyn Halonen; Anne L Wright; Fernando D Martinez
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

4.  Tumor necrosis factor inhibition and invasive fungal infections.

Authors:  Scott G Filler; Michael R Yeaman; Donald C Sheppard
Journal:  Clin Infect Dis       Date:  2005-08-01       Impact factor: 9.079

5.  Alternaria infectoria brain abscess in a child with chronic granulomatous disease.

Authors:  E Hipolito; E Faria; A F Alves; G S de Hoog; J Anjos; T Gonçalves; P V Morais; H Estevão
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-25       Impact factor: 3.267

6.  Surface hydrophobin prevents immune recognition of airborne fungal spores.

Authors:  Vishukumar Aimanianda; Jagadeesh Bayry; Silvia Bozza; Olaf Kniemeyer; Katia Perruccio; Sri Ramulu Elluru; Cécile Clavaud; Sophie Paris; Axel A Brakhage; Srini V Kaveri; Luigina Romani; Jean-Paul Latgé
Journal:  Nature       Date:  2009-08-27       Impact factor: 49.962

Review 7.  Potential contribution of fungal infection and colonization to the development of allergy.

Authors:  David L Goldman; Gary B Huffnagle
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

8.  Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 4.

Authors:  Londa J Berghaus; James N Moore; David J Hurley; Michel L Vandenplas; Barbara P Fortes; Margreet A Wolfert; Geert-Jan Boons
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2009-09-03       Impact factor: 2.268

9.  Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.

Authors:  David W Denning; B Ronan O'Driscoll; Georgina Powell; Fiona Chew; Graham T Atherton; Aashish Vyas; John Miles; Julie Morris; Robert M Niven
Journal:  Am J Respir Crit Care Med       Date:  2008-10-23       Impact factor: 21.405

Review 10.  Alternaria infections: laboratory diagnosis and relevant clinical features.

Authors:  F J Pastor; J Guarro
Journal:  Clin Microbiol Infect       Date:  2008-08       Impact factor: 8.067

View more
  3 in total

1.  Vulvovaginal Candida albicans Clinical Isolates' Resistance to Phagocytosis In-Vitro.

Authors:  Paula Faria-Gonçalves; Ana Sofia Oliveira; Carlos Gaspar; Lisa Rodrigues; Rita Palmeira-de-Oliveira; José Martinez-de-Oliveira; Teresa Gonçalves; Ana Palmeira-de-Oliveira; Joana Rolo
Journal:  Life (Basel)       Date:  2022-06-04

2.  Galectin-3 Is a Crucial Immunological Disease Marker in Patients with Fungal Keratitis.

Authors:  Yichen Xiao; Jiahui Yang; Zhenyuan Fu; Dalian He; Naiyang Li; Jin Yuan
Journal:  Dis Markers       Date:  2022-07-08       Impact factor: 3.464

Review 3.  The Pathogenesis of Aspergillus fumigatus, Host Defense Mechanisms, and the Development of AFMP4 Antigen as a Vaccine.

Authors:  Xiang Gu; Yan-Hong Hua; Yang-Dong Zhang; D I Bao; Jin Lv; Hong-Fang Hu
Journal:  Pol J Microbiol       Date:  2021-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.